Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
Titel:
Analysis of Toxicity and Clinical Outcomes in Full Versus Reduced Starting Dose Cabozantinib in Metastatic Renal Cell Carcinoma Patients
Auteur:
Martini, Dylan J. Evans, Sean T. Liu, Yuan Shabto, Julie M. Uner, Ogul E. Olsen, T. Anders Brown, Jacqueline T. Russler, Greta Anne Yantorni, Lauren Caulfield, Sarah Goldman, Jamie M. Nazha, Bassel Harris, Wayne B. Master, Viraj A. Kucuk, Omer Carthon, Bradley C. Bilen, Mehmet Asim